日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimizing phenobarbital dosing in critically ill patients with refractory and superrefractory status epilepticus using a population pharmacokinetic model

利用群体药代动力学模型优化难治性和超难治性癫痫持续状态危重患者的苯巴比妥给药方案

Stoschus, Maximilian; Schmidbauer, Moritz L; Starp, Johannes; Kunst, Stefan; Gakis, Georgios; Paal, Michael; Vogeser, Michael; Scharf-Janssen, Christina; Liebchen, Uwe; Dimitriadis, Konstantinos

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring

一种用于定量分析血浆中囊性纤维化药物(卡夫托斯)的液相色谱-串联质谱法及其在治疗监测中的应用

D'Atri, Valentina; Corrado, Fabrizio; Versace, François; Saldanha, Susana Alves; Mercier, Thomas; Guidi, Monia; Thoueille, Paul; Blanchon, Sylvain; Koutsokera, Angela; Vogeser, Michael; Marzolini, Catia; Girardin, François; Mitropoulou, Georgia; Balmpouzis, Zisis; Rochat, Isabelle; Sauty, Alain; Decosterd, Laurent Arthur; Choong, Eva

Lactate Clearance of the Adsorber Cytosorb(®) in Critically Ill Patients: A Post-Hoc Analysis of the Cyto-SOLVE Trial

Cytosorb®吸附剂在危重患者中的乳酸清除率:Cyto-SOLVE试验的事后分析

Wustrow, Vassilissa; Gräfe, Caroline; Graf, Helen; Scheiermann, Patrick; Paal, Michael; Vogeser, Michael; Liebchen, Uwe; Scharf, Christina

Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study

基于模型的重症患者接受SLEDD方案治疗时美罗培南优化给药策略的识别:一项观察性研究

Weber, Franz; Scharf, Christina; Aulin, Linda B S; Weinelt, Ferdinand; Paal, Michael; Mikus, Gerd; Vogeser, Michael; Habler, Katharina; Huisinga, Wilhelm; Zoller, Michael; Michelet, Robin; Kloft, Charlotte; Liebchen, Uwe

First therapeutic drug monitoring of experimental favipiravir in Borna disease virus 1 (BoDV-1) encephalitis patients reveals significant gaps in antiviral treatment: a pilot investigation

对博尔纳病毒1型(BoDV-1)脑炎患者进行实验性药物法匹拉韦的首次治疗药物监测揭示了抗病毒治疗方面的重大不足:一项初步研究

Paal, Michael; Habler, Katharina; Ewert, Alice; Vogeser, Michael; Grosse, Leonie; Lieftüchter, Victoria; Tauber, Simone C; Schiefer, Johannes; Allartz, Petra; Tappe, Dennis; Pörtner, Kirsten

Evaluation of the detuning ratio as a tool to detect potential interference in LC-MSMS analysis.

评估失谐率作为检测 LC-MSMS 分析中潜在干扰的工具

Rexhaj Arber, Vogeser Michael, Habler Katharina

Patient safety through quality assurance in in-vitro diagnostics - webinar 2024 of the Ad-hoc Commission on In-vitro Diagnostics of the Association of the Scientific Medical Societies in Germany (AWMF)

通过体外诊断质量保证保障患者安全——德国科学医学协会联合会(AWMF)体外诊断特设委员会2024年网络研讨会

Vogeser, Michael; Brüggemann, Monika; Sack, Ulrich; Stenzinger, Albrecht; Schliephake, Henning

Medical laboratory diagnostics in Germany - a status report 2024

德国医学实验室诊断——2024年现状报告

Vogeser, Michael; Schumacher, Timo; Bühling, Frank

Reply to Gatti and Pea, "Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?"

回复 Gatti 和 Pea 的问题:“在由脑部感染患者和脑外感染患者组成的混合人群中,对美罗培南脑脊液进行的药代动力学研究数据,真的对治疗中枢神经系统感染的临床医生有帮助吗?”

Wicha, Sebastian G; Kinast, Christina; Münchow, Max; Wittova, Sandra; Greppmair, Sebastian; Kunzelmann, Alexandra K; Zoller, Michael; Paal, Michael; Vogeser, Michael; Habler, Katharina; Weig, Thomas; Terpolilli, Nicole; Heck, Suzette; Dimitriadis, Konstantinos; Scharf, Christina; Liebchen, Uwe

Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study

美罗培南在脑脊液中的药代动力学:比较危重患者间歇输注和持续输注策略——一项前瞻性队列研究

Wicha, Sebastian G; Kinast, Christina; Münchow, Max; Wittova, Sandra; Greppmair, Sebastian; Kunzelmann, Alexandra K; Zoller, Michael; Paal, Michael; Vogeser, Michael; Habler, Katharina; Weig, Thomas; Terpolilli, Nicole; Heck, Suzette; Dimitriadis, Konstantinos; Scharf, Christina; Liebchen, Uwe